Search
Search
About
Log in
Join
Experiences with
Clinical trials
Posts
Communities
15,857 public posts
Filter results
Provenge Underway
Morning folks, Well I completed my first cycle of Provenge yesterday and all seems well so far. I also met with MO to review recent genetic testing results and have confirmed a mutation BRiP1 which is associated with autosomal dominant hereditary ovarian cancer, autosomal recessive Fanconia anemia,
Morning folks, Well I completed my first cycle of Provenge yesterday and all seems well so far. I also met with MO to review recent genetic testing results and have confirmed a mutation BRiP1 which is associated with autosomal dominant hereditary ovarian cancer, autosomal recessive Fanconia anemia,
Pmann
in
Advanced Prostate Cancer
6 months ago
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - MedPage Today, November 1, 2023
Modified dosing schedule from phase III randomized CABASTY trial for Jetvana (+ G-CSF) for older patients out of non-chemo treatment options. * * * [i]
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold
Modified dosing schedule from phase III randomized CABASTY trial for Jetvana (+ G-CSF) for older patients out of non-chemo treatment options. * * * [i]
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold
CaptnMojoe
in
Fight Prostate Cancer
6 months ago
ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC
Looks like a number of Drug companies are creating drugs that interact with the AR’s N-terminal domain and ligand-binding domain, impeding cell growth and enabling AR degradation. ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC October 27, 2023 Investigators will assess
Looks like a number of Drug companies are creating drugs that interact with the AR’s N-terminal domain and ligand-binding domain, impeding cell growth and enabling AR degradation. ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC October 27, 2023 Investigators will assess
Scout4answers
in
Advanced Prostate Cancer
6 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Annovis Bio Clinical Trials Update . . .
Strong interest being shown in Annovis Bio Parkinsons
clinical
trials
https://stocks.apple.com/A5Vy9P2FBSVmyh_y-Zvz_GQ
Strong interest being shown in Annovis Bio Parkinsons
clinical
trials
https://stocks.apple.com/A5Vy9P2FBSVmyh_y-Zvz_GQ
redhawk1
in
Cure Parkinson's
1 year ago
Clinical trials for AML
Hi. Since I had a abmt in July I have been visiting the hospital 3 times a week. I have become friendly with a couple and the wife who has aml is always needing platelets or something. Her transplant has been put on hold because of her blood levels and sadly their consultant is not being very informative
Hi. Since I had a abmt in July I have been visiting the hospital 3 times a week. I have become friendly with a couple and the wife who has aml is always needing platelets or something. Her transplant has been put on hold because of her blood levels and sadly their consultant is not being very informative
Kraskie1915
in
Leukaemia CARE
1 year ago
ER+ PR+ HER2-
My dr was one of the clinicians for the
clinical
trials
of Ibrance when he was a breast cancer dr ( he switched Gyn cancers when came to the place where I get my care). So I was one of the very few endometrial cancer patients to receive it in the USA.
My dr was one of the clinicians for the
clinical
trials
of Ibrance when he was a breast cancer dr ( he switched Gyn cancers when came to the place where I get my care). So I was one of the very few endometrial cancer patients to receive it in the USA.
Merma
in
SHARE Ovarian Cancer Support
1 year ago
Shingrix may be available on Australia's National Immunisation Program for those with CLL from 1 November 2023
[/i] [i]In
clinical
trials
, Zostavax efficacy was lower and decreased with increasing age (70% in people aged 50-59 years, 64% in those aged 60-69 years, 41% in 70-79 years, and 18% in 80-89 years (no longer statistically significant in this age group)."
[/i] [i]In
clinical
trials
, Zostavax efficacy was lower and decreased with increasing age (70% in people aged 50-59 years, 64% in those aged 60-69 years, 41% in 70-79 years, and 18% in 80-89 years (no longer statistically significant in this age group)."
CLLerinOz
Volunteer
in
CLL Support
10 months ago
Combining the Influenza and COVID-19 vaccines.
I have read of some people who got both vaccines at the same time, and their experience was not good. However perhaps a different kind of Influenza vaccine combined with a COVID-19 vaccine might make things easier.? This approach is now being tested. Pfizer and BioNTech Announce Positive Topline
I have read of some people who got both vaccines at the same time, and their experience was not good. However perhaps a different kind of Influenza vaccine combined with a COVID-19 vaccine might make things easier.? This approach is now being tested. Pfizer and BioNTech Announce Positive Topline
Kwenda
in
CLL Support
6 months ago
Masofaniten +Enzalutamide This could be a game changer...Science is coming to our aid
This is a company that I was turned on to by Nalkrantz before he was removed from this board. He told me that he was in touch with a doctor that was involved with this drug. Reportedly the early testing on a single patient had been phenomenal. These are pretty amazing #s NEWS PROVIDED BY ESSA
This is a company that I was turned on to by Nalkrantz before he was removed from this board. He told me that he was in touch with a doctor that was involved with this drug. Reportedly the early testing on a single patient had been phenomenal. These are pretty amazing #s NEWS PROVIDED BY ESSA
Scout4answers
in
Advanced Prostate Cancer
6 months ago
Cognition Issues
My husband is going into year 7 with PC. He had prostate removed… at Mayo in 2017. All clear margins, contained etc. 6 months he had Biochemical Recurrence. Then radiation and cryptography on one node. Since then he has been intermittently on ADT until he because Castrate resistant about a year ago
My husband is going into year 7 with PC. He had prostate removed… at Mayo in 2017. All clear margins, contained etc. 6 months he had Biochemical Recurrence. Then radiation and cryptography on one node. Since then he has been intermittently on ADT until he because Castrate resistant about a year ago
JolleySprings
in
Advanced Prostate Cancer
6 months ago
Update on Prostate Cancer Vaccines that I follow... another year is gone...
Greetings FPC forum, It has been another year... and I would love to have better news... there is a new vaccine candidate to monitor, but the reality is that the system takes time... The system needs a revision in my opinion, but I digress... As I reviewed the last time, the vaccine trial for RhoVac's
Greetings FPC forum, It has been another year... and I would love to have better news... there is a new vaccine candidate to monitor, but the reality is that the system takes time... The system needs a revision in my opinion, but I digress... As I reviewed the last time, the vaccine trial for RhoVac's
NPfisherman
in
Fight Prostate Cancer
6 months ago
A shared story of SCA3
The CPTA aims to optimize
clinical
trials
for inherited Ataxias. Impact stories like theirs can help researchers & drug developers understand the realities of living with Ataxia. You can read it here: https://c-path.org/impact_story/cpta-impact-through-optimization-of-clinical-trial-design/
The CPTA aims to optimize
clinical
trials
for inherited Ataxias. Impact stories like theirs can help researchers & drug developers understand the realities of living with Ataxia. You can read it here: https://c-path.org/impact_story/cpta-impact-through-optimization-of-clinical-trial-design/
wobblybee
in
Ataxia UK
1 year ago
Clinical Trial Dallas UT Southwestern
Will begin a Pfizer starting on Monday. I will post more later as it goes. We are adding a drug to Xtandi to treat solid tumors. I have been on and off Xtandi a few times. I am chemo naive. In the past had a very heavy tumor load and received 3 rounds of Lu-177 from Ishita Sen, Fortis health in Delhi
Will begin a Pfizer starting on Monday. I will post more later as it goes. We are adding a drug to Xtandi to treat solid tumors. I have been on and off Xtandi a few times. I am chemo naive. In the past had a very heavy tumor load and received 3 rounds of Lu-177 from Ishita Sen, Fortis health in Delhi
pilot52
in
Advanced Prostate Cancer
6 months ago
To those who replied to my question on clinical trials
To those who replied to my question on joining
clinical
trials
, I am overwhelmed by your kindness in sending me emails. I will answer your emails soon but I am currently recovering from a cataract operation and though my eyesight has improved a lot I still have difficulty reading and writing.
To those who replied to my question on joining
clinical
trials
, I am overwhelmed by your kindness in sending me emails. I will answer your emails soon but I am currently recovering from a cataract operation and though my eyesight has improved a lot I still have difficulty reading and writing.
MyMiracle13
in
SHARE Metastatic Breast Cancer
1 year ago
Care oncology
Hi I have stage 4 lung cancer and today have just found out that they are going to stop my immunotherapy as I have had to many side effects anyway my choices are to go back on chemo for a bit or I might be able to go a clinical trial. I've heard and read up a bit care oncology has anyone on here had
Hi I have stage 4 lung cancer and today have just found out that they are going to stop my immunotherapy as I have had to many side effects anyway my choices are to go back on chemo for a bit or I might be able to go a clinical trial. I've heard and read up a bit care oncology has anyone on here had
Leni22
in
The Roy Castle Lung Cancer Foundation
6 months ago
NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera
We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has recently released Final Guidance recommending Ruxolitinib for treating Polycythaemia Vera (PV) in adults in England who cannot tolerate Hydroxycarbamide (also called Hydroxyurea) or when the condition is
We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has recently released Final Guidance recommending Ruxolitinib for treating Polycythaemia Vera (PV) in adults in England who cannot tolerate Hydroxycarbamide (also called Hydroxyurea) or when the condition is
Mazcd
MPNVoice
in
MPN Voice
6 months ago
HAS ANYONE PARTICIPATED IN CLINICAL TRIALS
For those who have joined
clinical
trials
, did you have to undergo this very grueling screening test?
For those who have joined
clinical
trials
, did you have to undergo this very grueling screening test?
MyMiracle13
in
SHARE Metastatic Breast Cancer
1 year ago
PT-112 Immunotherapy Trial
Hi fellow travelers, Maxone73posted this sumary of interesting developments yesterday: https://healthunlocked.com/advanced-prostate-cancer/posts/150097372/new-hopes-we-all-need-them-on-a-monday So I thought that I would raise my my hand and say “I’m on the trial!” It’s NCT02266745, and here’s the
Hi fellow travelers, Maxone73posted this sumary of interesting developments yesterday: https://healthunlocked.com/advanced-prostate-cancer/posts/150097372/new-hopes-we-all-need-them-on-a-monday So I thought that I would raise my my hand and say “I’m on the trial!” It’s NCT02266745, and here’s the
TeleGuy
in
Advanced Prostate Cancer
6 months ago
CAR T-cell therapy IMPT-514 gets FDA fast track designation for lupus
Investigational treatment targets active, resistant lupus nephritis and SLE The U.S. Food and Drug Administration (FDA) has granted fast track designation to IMPT-514, a CAR T-cell therapy being developed by Immpact Bio for people with active, treatment-resistant lupus nephritis and systemic lupus
Investigational treatment targets active, resistant lupus nephritis and SLE The U.S. Food and Drug Administration (FDA) has granted fast track designation to IMPT-514, a CAR T-cell therapy being developed by Immpact Bio for people with active, treatment-resistant lupus nephritis and systemic lupus
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
6 months ago
Intensified Saphnelo dosing seen to benefit lupus nephritis patients
lupusnewstoday.com/news/intensified-dosing-of-saphnelo-seen-to-benefit-lupus-nephritis-patients/ October 16, 2023 Treatment with an intensified dosing regimen of Saphnelo (anifrolumab) led to greater improvements in kidney function compared with standard dosing or a placebo for people with active
lupusnewstoday.com/news/intensified-dosing-of-saphnelo-seen-to-benefit-lupus-nephritis-patients/ October 16, 2023 Treatment with an intensified dosing regimen of Saphnelo (anifrolumab) led to greater improvements in kidney function compared with standard dosing or a placebo for people with active
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
6 months ago
1
...
19
20
21
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Atrial Fibrillation Support
4065 results
Anxiety and Depression Support
2487 results
Advanced Prostate Cancer
1367 results
View top 10 communities
Sort by
Most Relevant
Newest